Clinical Trial Update: Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes

View source ↗

Summary

A recruiting clinical trial evaluating myocardial perfusion cardiac MRI to differentiate and characterize hypertrophic cardiomyopathy phenotypes, including pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anderson-fabry Disease
• Cardiac Amyloidosis
• Hypertrophic Cardiomyopathy

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease | Status: RECRUITING